[Adjuvant topical chemotherapy with cisplatin in superficial bladder cancer].
During a period of 6 weeks we applied a weekly dosage of 50 mg of cis-platinum as an intravesical instillation treatment to 30 patients with superficial carcinomas of the urinary bladder. Prior to this treatment these patients had undergone a transurethral differentiated resection of their tumours by multiple biopsies (mapping). Persistent tumours were found in 3 patients (10%). After an observation time of 22 months the relapse rate in pTa tumours was 5.5 and in pT1 tumours 7.6.
D000287:Administration, Topical; D000368:Aged; D002945:Cisplatin / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D009367:Neoplasm Staging; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery
D002945:Cisplatin
Adjuvante topische Chemotherapie mit Cis-Platin beim oberflächlichen Harnblasenkarzinom.